Skip to main content

Developing a National Registry of Pharmacologic and Biologic Clinical Trials Workshop Report (2006) / Chapter Skim
Currently Skimming:

6 Conclusion and Next Steps
Pages 43-46

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 43...
... The discussions at the workshop centered on the following five concepts: Purpose. There was little or no controversy over whether a regis try should track the status of individual clinical trials and provide a complete record of all trials to aid in doing systematic reviews of the evidence.
Read the entire page →
From page 44...
... The international pharmaceutical industry working with the National Library of Medicine (NLM) has begun registering all but exploratory clinical trials on ClinicalTrials.gov, and providing the results of clinical trials on marketed products on ClinicalStudyResults.gov, an Internet database launched in September 2004 by the Pharmaceutical Research and Manufacturers of America.
Read the entire page →
From page 45...
... CONCLUSION AND NEXT STEPS 45 leagues at NLM (2005) noted that, between May and October 2005, there was a large increase (73 percent)
Read the entire page →

Key Terms

  • clinical trials
  • national library


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.